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Oxidative stressAbstract Haloperidol (HP) is a classic antipsychotic drug known for its propensity to cause
extrapyramidal side effects. HP is known to induce oxidative stress due to increased turnover of
dopamine. The aim of the present study was to investigate the effect of sucrose (1 and 5 mg/kg; p.o.)
and grape seed extract (GSE; 100, 200 and 400 mg/kg; p.o.) on the oxidative stress induced in rats
by HP (1 mg/kg; p.o.) in the liver and the brain tissues. Oxidative stress was induced by injection of
HP for 14 consecutive days which was concurrently administered with sucrose and GSE. Liver and
brain levels of malondialdehyde (MDA), reduced glutathione (GSH), nitric oxide (nitrite) levels were
determined in the brain and liver. Results of the present study revealed that HP-treated rats showed
elevated levels of NO in the brain and MDA in the brain and liver. HP-treated rats showed also
decreased levels of NO levels in the liver and GSH in the brain and liver. Treatment of HP-treated
rats with GSE reversed all the oxidative stress markers in both the brain and liver due to its potent
antioxidant property. On the other hand, sucrose attenuates the levels of NO in the brain and liver
and the brain levels of MDA and GSH. It can be concluded that both GSE (a potent anti-oxidant)
and sucrose (as a source of energy) have beneﬁcial impacts on the brains of HP-treated rats.
However, GSE is more potent in alleviating the oxidative stress associated with HP in the liver.
ª 2015 Production and hosting by Elsevier B.V. on behalf of Faculty of Pharmacy, Cairo University.1. Introduction
Haloperidol (HP), a butyrophenone, has been used as an
antipsychotic drug in human. Unfortunately, the therapeutic
effects of HP are accompanied by severe extrapyramidal side
effects, resulting in movement disorders in patients. HP has
been used clinically in the treatment of psychiatry, obstetrics,and anesthesiology, and its pharmacology has been widely
reported.1,2
There has been increasing indication, implicating oxidative
stress as a causative factor in neuropsychotic disorders includ-
ing schizophrenia.3,4 Free radicals have been implicated in the
pathogenesis and clinical course of neuropsychiatric disorders
such as schizophrenia and in the development of tardive
dyskinesia. Increased superoxide dismutase (SOD) activity
has been reported in the red blood cells of schizophrenic
patients by some groups.5–7 Abnormal activity of catalase
(CAT) has also been reported.8 Some studies have shown
decreased CAT and increased SOD in schizophrenic patients.6
Increased blood levels of malondialdehyde MDA have been
30 S.A. El-Awdan et al.found in schizophrenic patients relative to normal controls.9
The brain is deﬁcient in oxidative defense mechanisms and
hence is at a greater risk of damage mediated by reactive oxy-
gen species (ROS), resulting in molecular and cellular dysfunc-
tions.10 ROS can damage virtually any biological molecule in
its vicinity, including DNA, essential proteins and membrane
lipids.11 There have been reports of membrane pathologies
and alterations in membrane phospholipids, essential fatty
acids and signal transduction,12 which are believed to be
ROS mediated.
Chronic treatment of HP is known to induce oxidative
stress due to increased turnover of dopamine.13 HP is cytotoxic
to primary hippocampal neurons.14 It was demonstrated that it
causes necrotic death rather than apoptotic. Some studies
reported the cytotoxic nature of HP but have not speciﬁed
the type of cell death.15 Others in their investigations, have
demonstrated that amyloid beta resistant cells were opposed
to HP toxicity, implying the role of free radicals in HP-induced
cell death.16 Typical neuroleptics such as HP and chlorpro-
mazine are known to cause oxidative stress,16 which is
thought to be responsible for its extrapyramidal side
effects.16,17 It has also been shown that increasing doses of
HP in rats17 attenuate the extrapyramidal side effects caused
by the same drug. Previous research has also shown that coad-
ministration of haloperidol and antioxidants such as vitamin E
resulted in a beneﬁcial effect in patients with tardive
dyskinesia.18
The aim of the present study was to investigate the effect
of sucrose (as a source of energy) and grape seed extract (as
a potent antioxidant) on the oxidative stress induced in rats
by HP in both the liver and the brain. Oxidative stress was
induced by injection of HP for 14 consecutive days which
was concurrently administered with sucrose and GSE.
Liver and brain levels of some relevant biomarkers for
oxidative stress and nitric oxide (NO) were determined.
Lipid peroxide levels (measured as malondialdehyde;
MDA) were taken as in vivo reliable indices for the con-
tribution of free radical generation in oxidative stress.
Nitrate/nitrite levels were used as a convenient marker for
NO formation.
2. Materials and methods
2.1. Animals
Rats with 120–150 g of body weight were used. Rats were
obtained from animal house colony of the National
Research Centre (Cairo, Egypt). Rats were housed under stan-
dardized conditions with free access to standard laboratory
food and water. Animal procedures were performed in accor-
dance with the Ethics Committee of the National Research
Centre and followed the recommendations of the National
Institutes of Health Guide for Care and Use of Laboratory
Animals (Publication No. 85-23, revised 1985). Equal groups
of 6 rats each were used in all experiments.
2.2. Drugs and chemicals
Grape seed extract (Mepaco, Egypt), haloperidol
(ChemiPharm, Egypt), sucrose were used in the presentinvestigation. They were freshly prepared in distilled water
and given orally. Thiobarbituric acid (TBA) was purchased
from Merck (Germany). All other chemicals were of the
highest commercially available grade.
2.3. Experimental design
Rats were randomly allocated into seven groups (8–10 rats
each) and the following groups were studied: Group I: contain-
ing rats receiving saline. Group II: containing rats receiving
HP (1 mg/kg). Group III: containing rats receiving HP
(1 mg/kg) and sucrose (1 mg/kg; p.o.). Group IV: containing
rats receiving HP (1 mg/kg) and sucrose (5 mg/kg; p.o.).
Group V: containing rats receiving HP (1 mg/kg) and GSE
(100 mg/kg; p.o.). Group VI: containing rats receiving HP
1 mg/kg and GSE (200 mg/kg; p.o.). Group VII: containing
rats receiving HP (1 mg/kg) and GSE (400 mg/kg; p.o.).
Twenty-four hours after the last dose, the rats were
sacriﬁced by cervical dislocation, the liver and brain were
isolated and homogenized in phosphate buffer.2.3.1. Biochemical analysis
Rats were euthanized by decapitation under ether anesthesia,
brains and livers were excised, washed with ice-cold saline
solution (0.9% NaCl), weighed and stored at 80 C for
biochemical analyses. The liver was homogenized with 0.1 M
phosphate buffer saline at pH 7.4, to give a ﬁnal concentration
of 10% w/v for biochemical assays.
2.3.2. Determination of nitric oxide
Nitric oxide measured as nitrite was determined by using
Griess reagent, according to the method of Moshage et al.
(1995) where nitrite, stable end product of NO radical, is
mostly used as an indicator for the production of NO.19
2.3.3. Determination of lipid peroxidation
Lipid peroxidation was assayed by measuring levels of
malondialdehyde (MDA) in the brain and liver tissues.
Malondialdehyde was determined by measuring thiobarbituric
reactive species using the method of Ruiz-Larrea et al. (1994),
in which the thiobarbituric acid reactive substances react with
thiobarbituric acid to produce a red colored complex having
peak absorbance at 532 nm.20
2.3.4. Determination of reduced glutathione
Reduced glutathione (GSH) was determined by Ellman’s
method (1959). The procedure is based on the reduction of
Ellman’s reagent by –SH groups of GSH to form 2-nitro-
s-mercaptobenzoic acid, the nitromercaptobenzoic acid anion
has an in-tense yellow color which can be determined
spectrophotometrically.212.4. Statistical analysis
Drug effects on HP-induced biochemical changes were
expressed as the mean ± SEM. Data were analyzed with a
one-way ANOVA followed by post hoc comparisons using
Tukey’s multiple comparisons test.
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3.1. Biochemical parameters measured in the brain
3.1.1. Effect of sucrose and GSE on nitric oxide
The oxidative stress induced in rats by HP is associated with an
increase in the brain NO levels reaching about 138% of the
normal value. Treatment of HP-treated rats with sucrose (1
and 5 mg/kg/day; p.o.) for 14 days showed a decrease in the
elevated brain NO levels reaching nearly the normal value.
Similar treatment of HP-treated rats with GSE (100, 200 and
400 mg/kg/day; p.o.) showed a decrease in the brain NO levels
by about 17%, 25% and 36%, respectively (Fig. 1a).
3.1.2. Effect of sucrose and GSE on lipid peroxidation
The oxidative stress induced in rats by HP is associated with
an increase in the brain lipid peroxidation levels (measured0.0
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Figure 1 Effects of sucrose and GSE on the brain (a) and liver (b) NO
stress was induced using haloperidol (1 mg/kg) then rats were given sucr
sucrose, rats were euthanized by decapitation and the brain and the liv
NO content determination. Statistical analysis was carried out by AN
difference from the corresponding normal control group at P< 0.0
P< 0.05.as MDA) reaching about 137% of the normal value.
Treatment of HP-treated rats with sucrose (5 mg/kg/day;
p.o.) for 14 days showed a decrease in elevated brain
MDA levels by about 32%. Similar treatment of HP-
treated rats with GSE (100, 200 and 400 mg/kg/day; p.o.)
showed a decrease in brain MDA levels reaching nearly
the normal value (Fig. 2a).3.1.3. Effect of sucrose and GSE on reduced glutathione
The oxidative stress induced in rats by HP is associated with a
decrease in brain GSH levels reaching about 57% of the nor-
mal value. Treatment of HP-treated rats with sucrose (1 and
5 mg/kg/day; p.o.) for 14 days showed an increase in reduced
brain GSH levels by about 17% and 21%, respectively.
Similar treatment of HP-treated rats with GSE (100, 200 and
400 mg/kg/day; p.o.) showed an increase in brain GSH levels
by about 34%, 63% and 80%, respectively (Fig. 3a).HP+Sucrose (1 mg/kg)
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Figure 2 Effects of sucrose and GSE on the brain (a) and liver (b) NO content in haloperidol-induced oxidative stress in rats. Oxidative
stress was induced using haloperidol (1 mg/kg) then rats were given sucrose and GSE for 2 weeks. Twenty-four hours after the last doses of
sucrose, rats were euthanized by decapitation and the brain and the liver were excised and homogenized. The homogenates were used for
NO content determination. Statistical analysis was carried out by ANOVA followed by Tukey’s multiple comparisons test. *Signiﬁcant
difference from the corresponding normal control group at P< 0.05. @Signiﬁcant difference from the haloperidol-treated group at
P< 0.05.
32 S.A. El-Awdan et al.3.2. Biochemical parameters measured in the liver
3.2.1. Effect of sucrose and GSE on nitric oxide
The oxidative stress induced in rats by HP is associated with a
decrease in liver NO levels reaching about 61% of the normal
value. Treatment of HP-treated rats with sucrose (1 and
5 mg/kg/day; p.o.) for 14 days showed an increase in the
reduced liver NO levels by about 15% and 30%, respectively.
Similar treatment with GSE (200 and 400 mg/kg/day; p.o.)
showed an increase in liver NO levels by about 47% and
56%, respectively (Fig. 1b).
3.2.2. Effect of sucrose and GSE on lipid peroxidation
The oxidative stress induced in rats by HP is associated with
an increase in liver lipid peroxidation levels (measured as
MDA) reaching about 125% of the normal value.
Treatment of HP-treated rats with sucrose (1 mg/kg/day;
p.o.) for 14 days showed a decrease in elevated liver MDAlevels reaching nearly the normal value. On the other hand,
HP-treated rats with sucrose (5 mg/kg/day; p.o.) showed no
change in liver MDA levels. Similar treatment of HP-
treated rats with GSE (100 mg/kg/day; p.o.) showed no
change in liver MDA levels, however treatment with GSE
(200 and 400 mg/kg/day; p.o.) showed a decrease in liver ele-
vated MDA levels by about 8% and 18%, respectively
(Fig. 2b).3.2.3. Effect of sucrose and GSE on reduced glutathione
The oxidative stress induced in rats by HP is associated with a
decrease in liver GSH levels reaching about 70% of the normal
value. Treatment of HP-treated rats with sucrose (1 and
5 mg/kg/day; p.o.) for 14 days showed no change in liver
GSH levels. Similar treatment of HP-treated rats with GSE
(100, 200 and 400 mg/kg/day; p.o.) showed an increase in liver
GSH levels reaching about 92%, 111% and 124% of the nor-
mal value, respectively (Fig. 3b).
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Figure 3 Effects of sucrose and GSE on the brain (a) and liver (b) GSH content in haloperidol-induced oxidative stress in rats. Oxidative
stress was induced using haloperidol (1 mg/kg) then rats were given sucrose and GSE for 2 weeks. Twenty-four hours after the last doses of
sucrose, rats were euthanized by decapitation and the brain and the liver were excised and homogenized. The homogenates were used for
NO content determination. Statistical analysis was carried out by ANOVA followed by Tukey’s multiple comparisons test. *Signiﬁcant
difference from the corresponding normal control group at P< 0.05. @Signiﬁcant difference from the haloperidol-treated group at
P< 0.05.
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The present study provided further evidence that HP increases
the oxidative stress in the brain tissue i.e. decreases the reduced
GSH levels and increases the MDA levels in rat brain. HP is
found to increase oxidative stress mediated neuronal damage
in animals. This neuronal damage by pro-oxidant actions of
HP has led to suggest that its side effects resulted from induced
oxidative injury.22
Lipid peroxides, measured as MDA, which are expressed as
thiobarbituric acid reactive substances reﬂect a condition of
oxidative stress. MDA a marker of lipid peroxidation activ-
ity23 was associated with a marked and signiﬁcant decrease
in the level of reduced glutathione, an important antioxidant
defense mechanism. These results are in accordance with that
reported by other authors.24,25 Sagara had reported that HP
increases brain oxidative stress due to increased turnover ofdopamine.24 The present study also shows that the administra-
tion of HP-induced a similar oxidative stress in the liver.
Hepatic toxicity of the antipsychotic HP has been reported
in cultured rat hepatocytes26 and experimentally in Wistar
rats.27,28 Shivakumar et al. (1992) reported that HP blockade
of dopamine receptor increases dopamine turnover resulting
in excessive production of hydrogen peroxide and, thus, gener-
ates oxidative stress.17
Haloperidol-induced oxidative stress was associated with
an increased generation of brain NO which is a free radical
which can be deleterious to brain functions, where synthesis
of inducible nitric oxide synthase contributes to the activation
of apoptotic pathways in the brain. NO can react with many
other free radical i.e. superoxide radical, generation peroxyni-
trite radical causing oxidative changes to numerous tissues.29
On the other hand, HP-induced oxidative stress was associated
with a decrease in the liver NO content.
34 S.A. El-Awdan et al.Results of the current study revealed that treatment of HP-
treated rats with GSE (100, 200 and 400 mg/kg/day; p.o.)
reversed all the oxidative stress markers in both the brain
and liver i.e. increased the reduced GSH and decreased the
lipid peroxidation, measured as MDA. GSE is considered a
very potent antioxidant and exhibits numerous interesting
pharmacologic activities.30 It has been suggested to be of use
in treatment of several diseases.31 GSE contains polyphenols
including proanthocyanidins and procyanidins that showed
antioxidant and free radical scavengers, being more effective
than either ascorbic acid or vitamin E.32 Their effects include
the ability to increase intracellular vitamin C levels, decrease
capillary permeability and fragility and scavenge oxidants
and free radicals. Several studies have indicated that extracts
obtained from GSE inhibit enzyme systems that are responsi-
ble for the production of free radicals.33,34
Grape seed extract supplementation increased NO levels in
the liver tissue. In accordance with other studies GSE scav-
enger NO35 has a beneﬁcial effect on the liver by protecting
it against both tissue injury and the cytotoxic effects of invad-
ing microorganisms, parasites, and tumor cells. Thus, NO may
prevent liver tissue damage caused by oxidative stress.36
However, GSE (100, 200 and 400 mg/kg/day; p.o.) has a ben-
eﬁcial effect on the brain NO content.
On the other hand, treatment of HP-treated rats with
sucrose attenuates the levels of NO in the brain and liver
and the brain levels of MDA and GSH. However, low sucrose
dose decreased elevated liver MDA levels reaching nearly the
normal value. Many studies showed the anti-oxidative effects
of sucrose and sucrosyl oligosaccharides.37 The mechanism
of OH scavenging might be linked to the presence of stable
oxidized sucrose free radical which are slower reacting radicals
compared with OH radicals and seem to undergo several pos-
sible reactions to form more stable non-radical compounds or,
alternatively, to regain their reduced forms. A previous study
reported that consumption of sucrose increased dopamine D3
receptor mRNA levels and decreased dopamine D2 receptor
mRNA levels.38 Sucrose fulﬁlls various functional roles in
plant metabolism. It might either directly detoxify reactive
oxygen species or indirectly stimulate the classic anti-
oxidative defense systems. On the other hand, treatment of
HP-treated rats with sucrose (5 mg/kg/day; p.o.) showed no
change in the liver contents of MDA and GSH. Spolarics
and his co-worker proposed that sucrose-rich diet results in
an increased hepatic sensitivity to oxidative stress.39 It has also
been suggested that sucrose-fed rats may predispose lipopro-
teins and subsequently oxidative stress.40
Finally, it can be concluded from all these ﬁndings that
both GSE (a potent anti-oxidant) and sucrose (as a source of
energy) have beneﬁcial impacts on the brains of HP-treated
rats. However, GSE is more potent in alleviating the oxidative
stress associated with HP in the liver.5. Conﬂict of interest
None.
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